Multiparametric MRI of rectal cancer in the assessment of response to therapy: A systematic review

Diseases of the Colon and Rectum

Volumn 57, Issue 6, 2014, Pages 790-799

  Hötker, Andreas M ^a   Garcia Aguilar, Julio ^a   Gollub, Marc J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

MRI; Neoadjuvant therapy; Rectal neoplasms

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INTERVENTION STUDY; MEDLINE; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIMARY TUMOR; PROSPECTIVE STUDY; RECTUM CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ADJUVANT THERAPY; DIAGNOSTIC USE; RECTAL NEOPLASMS;

CONTRAST MEDIUM;

CHEMORADIOTHERAPY, ADJUVANT; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; NEOADJUVANT THERAPY; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 84901793609     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000127     Document Type: Review

References (107)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479-1482. (Pubitemid 16095660)
3. Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30:1926-1933.
4. Habr-Gama A. Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy. Colorectal Dis. 2006;8(suppl 3):21-24.
5. Hartley A, Ho KF, McConkey C, Geh JI. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol. 2005;78:934-938. (Pubitemid 41582245)
6. Beets-Tan RG, Beets GL. Local staging of rectal cancer: a review of imaging. J Magn Reson Imaging. 2011;33:1012-1019.
7. Oberholzer K, Menig M, Kreft A, et al. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys. 2012;82:842-848.
8. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-999. (Pubitemid 16005611)
9. Gollub MJ, Maas M, Weiser M, et al. Recognition of the anterior peritoneal reflection at rectal MRI. AJR Am J Roentgenol. 2013;200:97-101.
10. Klessen C, Rogalla P, Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol. 2007;17:379-389. (Pubitemid 46140309)
11. Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G. MRI staging of low rectal cancer. Eur Radiol. 2009;19:643-650.
12. Smith N, Brown G. Preoperative staging of rectal cancer. Acta Oncol. 2008;47:20-31.
13. Szafer A, Zhong J, Anderson AW, Gore JC. Diffusion- weighted imaging in tissues: theoretical models. NMR Biomed. 1995;8:289-296.
14. Szafer A, Zhong J, Gore JC. Theoretical model for water diffusion in tissues. Magn Reson Med. 1995;33:697-712.
15. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102-125.
16. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7:91-101. (Pubitemid 28365643)
17. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223-232. (Pubitemid 29463104)
18. Beets-Tan RG. MRI in rectal cancer: the T stage and circumferential resection margin. Colorectal Dis. 2003;5:392-395. (Pubitemid 37080642)
19. Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-Analysis. Ann Surg Oncol. 2012;19:2212-2223.
20. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 2001;357:497-504. (Pubitemid 32173585)
21. Blomqvist L, Machado M, Rubio C, et al. Rectal tumour staging: MR imaging using pelvic phased-Array and endorectal coils vs endoscopic ultrasonography. Eur Radiol. 2000;10:653-660. (Pubitemid 30202653)
22. Akasu T, Iinuma G, Takawa M, Yamamoto S, Muramatsu Y, Moriyama N. Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer. Ann Surg Oncol. 2009;16:2787-2794.
23. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-312.
24. Patel UB, Taylor F, Blomqvist L, et al. Magnetic resonance imaging- detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol. 2011;29:3753-3760.
25. Ptok H, Ruppert R, Stassburg J, et al. Pretherapeutic MRI for decision- making regarding selective neoadjuvant radiochemotherapy for rectal carcinoma: interim analysis of a multicentric prospective observational study. J Magn Reson Imaging. 2013;37:1122-1128.
26. Oberholzer K, Junginger T, Heintz A, et al. Rectal cancer: MR imaging of the mesorectal fascia and effect of chemoradiation on assessment of tumor involvement. J Magn Reson Imaging. 2012;36:658-663.
27. Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones R. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roentgenol. 2007;188:442-451. (Pubitemid 46167747)
28. Chen CC, Lee RC, Lin JK, Wang LW, Yang SH. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum. 2005;48:722-728.
29. Kuo LJ, Chern MC, Tsou MH, et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum. 2005;48:23-28.
30. Barbaro B, Fiorucci C, Tebala C, et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology. 2009;250:730-739.
31. Torkzad MR, Påhlman L, Glimelius B. Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review. Insights Imaging. 2010;1:245-267.
32. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-A meta- analysis. Radiology. 2004;232:773-783. (Pubitemid 39100263)
33. Suppiah A, Hunter IA, Cowley J, et al. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer. Colorectal Dis. 2009;11:249-253.
34. van der Paardt MP, Zagers MB, Beets-Tan RG, Stoker J, Bipat S. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-Analysis. Radiology. 2013;269:101-112.
35. Poon FW, McDonald A, Anderson JH, et al. Accuracy of thin section magnetic resonance using phased-Array pelvic coil in predicting the T-staging of rectal cancer. Eur J Radiol. 2005;53:256-262. (Pubitemid 40143587)
36. Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors: the circumferential resection margin and nodal disease-of local recurrence in rectal cancer-A meta- analysis. Semin Ultrasound CT MR. 2005;26:259-268. (Pubitemid 41111583)
37. Kwok H, Bissett IP, Hill GL. Preoperative staging of rectal cancer. Int J Colorectal Dis. 2000;15:9-20.
38. Bown EJ, Lloyd GM, Boyle KM, Miller AS. Rectal cancer: prognostic indicators of long-term outcome in patients considered for surgery. Int J Colorectal Dis. 2014;29:147-155.
39. Wang Z, Zhou Z, Wang C, et al. Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections. Int J Colorectal Dis. 2005;20:231-237. (Pubitemid 40553001)
40. Koh DM, George C, Temple L, et al. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes. AJR Am J Roentgenol. 2010;194:W505-W513.
41. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high- spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003;227:371-377. (Pubitemid 36514749)
42. Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol. 2004;52:78-83. (Pubitemid 39233657)
43. Lambregts DM, Beets GL, Maas M, et al. Accuracy of gadofosveset- enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg. 2011;253:539-545.
44. Lambregts DM, Heijnen LA, Maas M, et al. Gadofosveset- enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria. Abdom Imaging. 2013;38:720-727.
45. Heijnen LA, Lambregts DM, Martens MH, et al. Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced? Eur Radiol. 2014;24:371-379.
46. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging: 1-fundamental concepts. Magn Reson Med. 1991;17:357-367.
47. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15:621-628.
48. Goh V, Padhani AR, Rasheed S. Functional imaging of colorectal cancer angiogenesis. Lancet Oncol. 2007;8:245-255. (Pubitemid 46291714)
49. Sauer R, Becker H, Hohenberger W, et al.; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. NEngl J Med. 2004;351:1731-1740.
50. Rödel C, Liersch T, Becker H, et al.; German Rectal Cancer Study Group. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012;13:679-687.
51. Marijnen CA, Kapiteijn E, van de Velde CJ, et al.; Cooperative Investigators of the Dutch Colorectal Cancer Group. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2002;20:817-825. (Pubitemid 34111391)
52. Peeters KCMJ. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-A Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199-6206.
53. Wallin U, Rothenberger D, Lowry A, Luepker R, Mellgren A. CEA: a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer. Dis Colon Rectum. 2013;56:859-868.
54. Quah HM, Chou JF, Gonen M, et al. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer. 2008;113:57-64. (Pubitemid 351976386)
55. Rödel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688-8696. (Pubitemid 46211512)
56. Park MJ, Kim SH, Lee SJ, Jang KM, Rhim H. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology. 2011;260:771-780.
57. Intven M, Reerink O, Philippens ME. Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-Adjuvant radiochemotherapy. Strahlenther Onkol. 2013;189:117-122.
58. Jung SH, Heo SH, Kim JW, et al. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J Magn Reson Imaging. 2012;35:110-116.
59. Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology. 2010;254:170-178.
60. Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002;360:307-308. (Pubitemid 34874724)
61. Cai G, Xu Y, Zhu J, et al. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation. World J Gastroenterol. 2013;19:5520-5527.
62. Curvo-Semedo L, Lambregts DM, Maas M, Beets GL, Caseiro- Alves F, Beets-Tan RG. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging. 2012;35:1365-1371.
63. Barbaro B, Vitale R, Valentini V, et al. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;83:594-599.
64. E lmi A, Hedgire SS, Covarrubias D, Abtahi SM, Hahn PF, Harisinghani M. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer. Clin Radiol. 2013;68:e524-e531.
65. Ippolito D, Monguzzi L, Guerra L, et al. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdom Imaging. 2012;37:1032-1040.
66. DeVries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys. 2003;56:958-965. (Pubitemid 36794026)
67. Musio D, De Felice F, Magnante AL, et al. Diffusion-weighted magnetic resonance application in response prediction before, during, and after neoadjuvant radiochemotherapy in primary rectal cancer carcinoma. Biomed Res Int. 2013;2013:740195.
68. Monguzzi L, Ippolito D, Bernasconi DP, Trattenero C, Galimberti S, Sironi S. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy. Eur J Radiol. 2013;82:234-240.
69. Lambregts DM, Beets GL, Maas M, et al. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol. 2011;21:2567-2574.
70. Mizukami Y, Ueda S, Mizumoto A, et al. Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg. 2011;35:895-899.
71. Lambregts DM, Maas M, Riedl RG, et al. Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-A per lesion validation study. Eur Radiol. 2011;21:265-273.
72. Heijnen LA, Lambregts DM, Mondal D, et al. Diffusion- weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Eur Radiol. 2013;23:3354-3360.
73. Cho EY, Kim SH, Yoon JH, et al. Apparent diffusion coefficient for discriminating metastatic from non-metastatic lymph nodes in primary rectal cancer. Eur J Radiol. 2013;82:e662-e668.
74. de Lussanet QG, Backes WH, Griffioen AW, et al. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol Phys. 2005;63:1309-1315. (Pubitemid 41628023)
75. Zhang XM, Yu D, Zhang HL, et al. 3D dynamic contrast- enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis. J Magn Reson Imaging. 2008;27:1309-1316. (Pubitemid 351770682)
76. Rudisch A, Kremser C, Judmaier W, Zunterer H, DeVries AF. Dynamic contrast-enhanced magnetic resonance imaging: a non-invasive method to evaluate significant differences between malignant and normal tissue. Eur J Radiol. 2005;53:514-519. (Pubitemid 40312144)
77. Lim JS, Kim D, Baek SE, et al. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2012;22:1693-1700.
78. Gollub MJ, Gultekin DH, Akin O, et al. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol. 2012;22:821-831.
79. Gollub MJ, Gultekin DH, Schwartz LH. Letter to the Editor re: perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2013;23:1297-1298.
80. Gramont A de, van Cutsem E, Schmoll H, et al. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial. Lancet Oncol. 2012;13:1225-1233.
81. Oberholzer K, Menig M, Pohlmann A, et al. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2013;38:119-126.
82. George ML, Dzik-Jurasz AS, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg. 2001;88:1628-1636. (Pubitemid 33124241)
83. Devries AF, Griebel J, Kremser C, et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res. 2001;61:2513-2516. (Pubitemid 32685831)
84. Dinter DJ, Horisberger K, Zechmann C, et al. Can dynamic MR imaging predict response in patients with rectal cancer undergoing cetuximab-based neoadjuvant chemoradiation? Onkologie. 2009;32:86-93.
85. Alberda WJ, Dassen HP, Dwarkasing RS, et al. Prediction of tumor stage and lymph node involvement with dynamic contrast- enhanced MRI after chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis. 2013;28:573-580.
86. Lollert A, Junginger T, Schimanski CC, et al. Rectal cancer: dynamic contrast-enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression. J Magn Reson Imaging. In press.
87. Franklin JM, Anderson EM, Gleeson FV. MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy. Clin Radiol. 2012;67:546-552.
88. Song I, Kim SH, Lee SJ, Choi JY, Kim MJ, Rhim H. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br J Radiol. 2012;85:577-586.
89. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology. 2009;253:116-125.
90. Kim SH, Lee JY, Lee JM, Han JK, Choi BI. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol. 2011;21:987-995.
91. Lambrecht M, Deroose C, Roels S, et al. The use of FDG- PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta Oncol. 2010;49:956-963.
92. Curvo-Semedo L, Lambregts DM, Maas M, et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy-conventional MR volumetry versus diffusion-weighted MR imaging. Radiology. 2011;260:734-743.
93. Ha HI, Kim AY, Yu CS, Park SH, Ha HK. Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remis sion after preoperative chemoradiation therapy. Eur Radiol. 2013;23:3345-3353.
94. Genovesi D, Filippone A, Ausili Cèfaro G, et al. Diffusion- weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study. Eur J Surg Oncol. 2013;39:1071-1078.
95. Lambrecht M, Vandecaveye V, De Keyzer F, et al. Value of diffusion- weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys. 2012;82:863-870.
96. Engin G, Sharifov R, Güral Z, et al. Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer? Diagn Interv Radiol. 2012;18:574-581.
97. Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusion- weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 2011;18:2224-2231.
98. Sassen S, de Booij M, Sosef M, et al. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur Radiol. 2013;23:3440-3449.
99. I ntven M, Reerink O, Philippens ME. Repeatability of diffusion- weighted imaging in rectal cancer. J Magn Reson Imaging. 2013 Oct 11. doi: 10.1002/jmri.24337. [Epub ahead of print].
100. Hötker AM, Schmidtmann I, Oberholzer K, Düber C. Dynamic contrast enhanced-MRI in rectal cancer: inter- and intraobserver reproducibility and the effect of slice selection on pharmacokinetic analysis. J Magn Reson Imaging. 2013 Oct 11. doi: 10.1002/jmri.24385. [Epub ahead of print]. doi: 10.1002/jmri.24385. [Epub ahead of print].
101. Martens MH, Papanikolaou N, Kluza E, Heijnen LA, eds. Is there a correlation between quantitative and qualitative parameters for dynamic contrast-enhanced MRI in rectal cancer? ESGAR 2013 [abstract].
102. RSNA . Quantitative Imaging Biomarkers Alliance Web site. http://www.rsna.org/QIBA.aspx. Accessed February 2, 2014.
103. Hosonuma T, Tozaki M, Ichiba N, et al. Clinical usefulness of diffusion-weighted imaging using low and high b-values to detect rectal cancer. Magn Reson Med Sci. 2006;5:173-177.
104. Rao SX, Zeng MS, Chen CZ, et al. The value of diffusion- weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur J Radiol. 2008;65:299-303.
105. Tamakawa M, Kawaai Y, Shirase R, et al. Gadoliniumenhanced dynamic magnetic resonance imaging with endorectal coil for local staging of rectal cancer. Jpn J Radiol. 2010;28:290-298.
106. Vliegen RF, Beets GL, von Meyenfeldt MF, et al. Rectal cancer: MR imaging in local staging-is gadolinium-based contrast material helpful? Radiology. 2005;234:179-188. (Pubitemid 39658384)
107. Yao WW, Zhang H, Ding B, et al. Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features. Radiol Med. 2011;116:366-374.